
GRI Bio, Inc. – NASDAQ:GRI
GRI Bio stock price today
GRI Bio stock price monthly change
GRI Bio stock price quarterly change
GRI Bio stock price yearly change
GRI Bio key metrics
Market Cap | 6.53M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -26.85 |
Revenue | N/A |
EBITDA | -12.32M |
Income | -12.77M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGRI Bio stock price history
GRI Bio stock forecast
GRI Bio financial statements
Jun 2023 | 0 | -6.74M | |
---|---|---|---|
Sep 2023 | 0 | -2.13M | |
Jan 2024 | 5.39M | -2.00M | -37.15% |
Mar 2024 | 0 | -1.88M |
Jun 2023 | 5642000 | 1.60M | 28.43% |
---|---|---|---|
Sep 2023 | 4404000 | 2.17M | 49.43% |
Jan 2024 | 2956000 | 2.69M | 91.24% |
Mar 2024 | 4587000 | 1.78M | 39% |
Jun 2023 | -3K | -8K | 6.91M |
---|---|---|---|
Sep 2023 | -1.31M | 0 | -11M |
Jan 2024 | -5.56M | 0 | 3.88M |
Mar 2024 | -2.20M | 0 | 4.48M |
GRI Bio alternative data
Aug 2023 | 1 |
---|---|
Sep 2023 | 1 |
Oct 2023 | 1 |
Nov 2023 | 1 |
Dec 2023 | 1 |
Jan 2024 | 1 |
Feb 2024 | 1 |
Mar 2024 | 1 |
Apr 2024 | 1 |
May 2024 | 4 |
Jun 2024 | 4 |
Jul 2024 | 4 |
GRI Bio other data
-
What's the price of GRI Bio stock today?
One share of GRI Bio stock can currently be purchased for approximately $1.39.
-
When is GRI Bio's next earnings date?
Unfortunately, GRI Bio's (GRI) next earnings date is currently unknown.
-
Does GRI Bio pay dividends?
No, GRI Bio does not pay dividends.
-
How much money does GRI Bio make?
GRI Bio has a market capitalization of 6.53M.
-
What is GRI Bio's stock symbol?
GRI Bio, Inc. is traded on the NASDAQ under the ticker symbol "GRI".
-
What is GRI Bio's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of GRI Bio?
Shares of GRI Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does GRI Bio have?
As Jul 2024, GRI Bio employs 4 workers, which is 300% more then previous quarter.
-
When GRI Bio went public?
GRI Bio, Inc. is publicly traded company for more then 4 years since IPO on 10 Feb 2021.
-
What is GRI Bio's official website?
The official website for GRI Bio is gribio.com.
-
Where are GRI Bio's headquarters?
GRI Bio is headquartered at 2223 Avenida de la Playa, LA Jolla, CA.
-
How can i contact GRI Bio?
GRI Bio's mailing address is 2223 Avenida de la Playa, LA Jolla, CA and company can be reached via phone at +61 94001170.
GRI Bio company profile:

GRI Bio, Inc.
gribio.comNASDAQ
4
Biotechnology
Healthcare
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
LA Jolla, CA 92037
CIK: 0000084112
ISIN: US3622AW2059
: